Latest News about FDA
Recent news which mentions FDA
Novel Psychedelic Compound For The Treatment Of Fibromyalgia Begins Dosing In Safety Trial
November 11, 2022
Tickers
SILO
From Benzinga
GSK Limits Second-Line Maintenance Use Of Its Ovarian Cancer Drug To Some Populations
November 11, 2022
Tickers
GSK
From Benzinga
From Benzinga
FDA Responds To Marijuana-Related Petition After More Than A Decade, Procrastinate Much?
November 10, 2022
From Benzinga
FDA Refuses To Accept BrainStorm Cell's Lead Candidate For Amyotrophic Lateral Sclerosis
November 10, 2022
Tickers
BCLI
From Benzinga
AstraZeneca Ditches US Application Submission For COVID-19 Shot, Q3 Edges Analyst Expectations On Oncology Strength
November 10, 2022
From Benzinga
From Benzinga
FDA Adcomm Backs AstraZeneca's 2-In-1 Asthma Inhaler, Only For Adults Being Less Sure For Adolescents, Kids
November 09, 2022
From Benzinga
From Benzinga
Veru Shares Jump Over 40% Despite FDA Staff Raises Uncertainties Over Its COVID-19 Therapy
November 07, 2022
Tickers
VERU
From Benzinga
Verve Therapeutics Shares Tumble After FDA Hold On Trial For Elevated Cholesterol Level Candidate
November 07, 2022
Tickers
VERV
From Benzinga
Why Are Apellis Pharmaceuticals Shares Falling Today?
November 04, 2022
From Benzinga
Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02
November 02, 2022
From Benzinga
EXCLUSIVE: SPAC Merger Partner ProSomnus' Sleep & Snore Device Scores FDA Approval
November 02, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.